Strong quarter-to-quarter recovery with net revenue up 200% and improved margins, despite a 9% year-on-year sales decline. ES sales rose 20% and gross margin reached 33%, aided by a non-recurring F-gas quota sale. Positive outlook continues with new products, distributors, and stable cost base.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.